zist-fan.ir/go/5601
Controversy over the efficiency of new diagnostic methods
At one time, individual DNA sequencing promised to increase the number of personalized medicines for individuals.
Venter, a pioneer in human genomics, went on to found a company called Health Nucleus in California that claims to be able to detect undiagnosed health problems by combining DNA analysis with a $25,000 test that includes a scan. A whole-body MRI, metabolomic screening, continuous cardiac monitoring for 2 weeks, racial screening, microbiome sequencing, and a battery of standard laboratory tests will identify patients.
T.me/zistfan
Recently, Venter and colleagues published a paper presenting data from the new project. According to the claim, in this study screening showed “age-related chronic diseases requiring immediate medical attention (less than 30 days)” in 8% of 209 participants and MRI detected early stages of cancer in 2% of participants. gave However, the presented results have not become official.
One of the media also said that Venter’s group can detect Alzheimer’s diseases 20 years earlier by scanning 20 areas of the brain, and in addition, their investigations can detect tumors early.
Critics of this claim point to a series of problems such as physiological harm, high medical costs and unnecessary tests. They say the term “precision medicine” is very difficult to accept, and the genome alone doesn’t tell you the whole story. You really need to show that you want to help people. On the other hand, fans say that the concern about this diagnosis is completely exaggerated. This study remains highly controversial and points to the need for rigorous substantiation of medical claims to establish public acceptance
Author: Mohammad Rezazadeh
Source: zist-fan.ir/go/5599
Bioeconomy channel:
t.me/bioeconomy
This post is written by motealehi